In addition to promote IL-23-mediated lung inflammation by targeting monocytes, COL6 was capable of activating signaling molecules (e.g., FAK and ERK) in normal lung epithelial cells, which may promote the development of lung cancer. This evidence concerns the gene IL23A and lung carcinoma.